23andMe co-founder and chief executive Anne Wojcicki would be open to considering third-party takeover proposals for the company, a regulatory filing, opens new tab showed on Wednesday.
The genetic testing firm’s shares were up 2.8% at $0.31 in extended trade.
In July, Wojcicki, who has been trying to take the company private, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share.
The filing also said the CEO continues to evaluate and negotiate a deal.
A special committee formed by the company rejected Wojcicki’s previous proposal, deeming it insufficient and not in the best interest of the non-affiliated shareholders.
Other alternatives will be pursued to maximize value for shareholders, in the absence of a revised offer, the committee said last month.
23andMe, best known for its saliva-based test kits that offer users a glimpse into their genetic ancestry, went public in 2021.
Get the latest news and expert analysis about the state of the global economy with the Reuters Econ World newsletter. Sign up here.